Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India

Annals of Clinical Microbiology and Antimicrobials

Volumn 14, Issue 1, 2015, Pages

  Rynga, Dabet ^a,b   Shariff, Malini ^a   Deb, Monorama ^b  

^a UNIVERSITY OF DELHI   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

Acinetobacter baumannii; Beta lactamases; MLST; Molecular characterization; RAPD

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIGECYCLINE; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; GENETIC VARIABILITY; INDIA; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; ACINETOBACTER INFECTIONS; CLASSIFICATION; DRUG EFFECTS; GENETIC VARIATION; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; RANDOM AMPLIFIED POLYMORPHIC DNA; SECRETION (PROCESS);

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENETIC VARIATION; GENOTYPE; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE;

EID: 84940783068     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/s12941-015-0101-5     Document Type: Article

References (35)

1. Peleg AY, Seifert H. Paterson DL Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538-82.
2. Chandra R, Kapil A, Sharma P, Das B. Identification of Acinetobacter species isolated from clinical specimens by amplified ribosomal DNA restriction analysis. Indian J Med Res. 2002;116:1-4.
3. Vaneechoutte M, Dijkshoorn L, Tjernberg I, Elaichouni A, de Vos P, Claeys G, Verschraegen G. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol. 1995;33:11-5.
4. Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Twenty-Third Informational Supplement(M100-S23), Wayne, PA.2013.
5. Wikler MA, editor. Performance standards for antimicrobial susceptibility testing; Eighteenth informational supplement. 18th ed. Wayne (PA): Clinical and Laboratory Standards institute; 2008.
6. Somily AM. Comparison of E-test and disc diffusion methods for the in vitro evaluation of the antimicrobial activity of colistin in multi-drug resistant Gram-negative bacilli. Saudi Med J. 2010;31:507-11.
7. Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM, Sader HS. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol. 2007;45:227-30.
8. Manchanda V, Sanchaita S, Singh NP. Multidrug resistant Acinetobacter. J Global Infect Dis. 2010;2:291-304.
9. Thomson KS. Extended-spectrum-beta-lactamase, AmpC, and carbapenemase issues. J Clin Microbiol. 2010;48:1019-25.
10. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2002;40:3798-801.
11. Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo beta-lactamases. J Antimicrob Chemother. 2007;59:321-2.
12. Black JA, Moland ES, Hossain A, Lockhart TJ, Olson LB, Thomson KS (2003) Abstr. 43rd intersci. Conf. Antimicrob. Agents Chemother., abstr C2-2034. Prevalence of plasmid-mediated AmpC β-lactamase in Klebsiella pneumoniae (kp), Klebsiella spp. and 21 non-ICU sites in the United States.
13. Karthika RU, Rao RS, Sahoo S, Shashikala P, Kanungo R, Jayachandran S. Prashanth K Phenotypic and genotypic assays for detecting the prevalence of metallo-beta-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital. J Med Microbiol. 2009;58:430-5.
14. Bartual SG, Seifert H, Hippler C. Doml'nguez Luzon MA, Wisplinghoff H, Rodrl'guez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005;43:4382-90.
15. Park YK, Jung SI, Park KH, Cheong HS, Peck KR, Song JH, Ko KS. Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea. Diagn Microbiol Infect Dis. 2009;64:43-51.
16. Sinha N, Agarwal J, Srivastava S, Singh M. Analysis of carbapenem resistant Acinetobacter from a tertiary care setting in North India. Indian J Med Microbiol. 2013;31:60-3.
17. Vila J, Martí S, Sánchez-Céspedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother. 2007;59:1210-5.
18. El-Ageery SM, Abo-Shadi MA, Alghaithy AA, Ahmad MA, Alsharif NH, Alharbi SA. Epidemiological investigation of nosocomial infection with multidrug-resistant Acinetobacter baumannii. Eur Rev Med Pharmacol Sci. 2012;16:1834-9.
19. Nwadike VU, Ojide CK, Kalu EI. Multidrug resistantAcinetobacterinfection and their antimicrobialsusceptibilitypattern in a Nigerian tertiary hospital ICU. Afr J Infect Dis. 2014;8:14-8.
20. Taneja N, Singh G, Singh M, Sharma M. Emergence of tigecycline and colistin resistant Acinetobacter baumannii in patients with complicated urinary tract infections in North India. Indian J Med Res. 2011;133:681-4.
21. Patwardhan RB, Dhakephalkar PK, Niphadkar KB, Chopade BA. A study on nosocomial pathogens in ICU with special reference to mutiresistant Acinetobacter baumannii harboring multiple plasmids. Indian J Med Res. 2008;128:178-87.
22. Ning D, De-zhi L, Ji-chao C, Yu-sheng C, Rong G, Ying-hui HU, Jing-ping Y, Juan D, Cheng-ping H, Wei Z, Jia-shu L, Qin Y, Huan-ying W, Lan M, Xiao-ning Z, Li-ping W, Jian-jun M, Qiu-yue W, Ke H, Gui-zhen T, Shao-xi C, Rui-qin W, Bei H, Si-qin W, Zhan-wei W, Su-rui Z, Zhan-cheng G. Drug-resistant genes carried by Acinetobacter baumannii isolated from patients with lower respiratory tract infection. Chin Med J. 2010;123:2571-5.
23. Lean SS, Suhaili Z, Ismail S, Rahman NIA, Othman N, Abdullah FH, Jusoh Z, Yeo CC, Thong KL. Prevalence and Genetic Characterization of Carbapenem- and Polymyxin-Resistant Acinetobacter baumannii Isolated from a Tertiary Hospital in Terengganu, Malaysia. ISRN, Microbiology. 2014;1:1-9.
24. Al-Agamy MH, Khalaf NG, Tawfick MM, Shibl AMA, Kholy AE. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis. 2014;22:49-54.
25. Denys GA, Callister SM, Dowzicky MJ. Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.). Ann Clin Microbiol Antimicrob. 2013;12:24-34.
26. Ertürk A, Çiçek AC, Gümüş A, Cüre E, Şen A, Kurt A, Karagöz A, Aydoğan N, Sandall Durmaz R. Molecular characterisation and control of Acinetobacter baumannii isolates resistant to multi-drugs emerging in inter-intensive care units. Ann Clin Microbiol Antimicrob. 2014;13:36-43.
27. Dettori M, Piana A, Deriu MG, Curto PL, Cossu A, Musumeci R, Cocuzza C, Astone V, Contu MA, Sotgiu G. Outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit. New Microbiol. 2014;37:185-91.
28. Shete VB, Ghadage DP, Muley VA, Bhore AV. Multi-drug resistant Acinetobacterventilator-associatedpneumonia. Lung India. 2010;27:217-20.
29. Shete VB, Ghadage DP, Muley VA, Bhore AV. Acinetobacter septicaemia in neonates admitted to intensive care units. J Lab Phys. 2009;1:73-6.
30. Said KB,Al-Jarbou AN,Alrouji M,Al-Harbi HO. Surveillance of antimicrobial resistance among clinical isolates recovered from a tertiary care hospital in Al Qassim, Saudi Arabia. Int J Health Sci (Qassim). 2014; 8:3-12.
31. Chang KC, Lin MF, Lin NT, Wu WJ, Kuo HY, Lin TY, Yang TL, Chen YC, Liou ML. Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan. J Microbiol Immunol Infect. 2012;45:37-42.
32. Behera B, Das A, Mathur P, Kapil A, Gadepalli R, Dhawan B. Tigecycline susceptibility report from an Indian tertiary care hospital. Indian J Med Res. 2009;129:446-50.
33. Spiliopoulou A,Jelastopulu E,Vamvakopoulou S,Bartzavali C,Kolonitsiou F,Anastassiou ED,Christofidou M. In vitro activity of tigecycline and colistin against A.baumanniiclinical bloodstream isolates during an 8-year period. J Chemother. 2014. doi: 10.1179/1973947814Y.0000000193[Epub ahead of print].
34. Lesho E, Yoon EJ, McGann P, Snesrud E, Kwak Y, Milillo, Onmus-Leone F, Preston L, St. Clair K, Nikolich M, Viscount H, Wortmann G, Zapor M, Grillot-Courvalin C, Courvalin P, Clifford R, Waterman PE. Emergence of colistin-resistance in extremely drug-resistantAcinetobacter baumannii containing a novelpmrCABoperon during colistin therapy of wound infections. J Infect Dis. 2013;208:1142-51.
35. Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2007;59:772-4.